PMCTPharmaCountry
    Home

Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#Synthon ×

UPDATED
Regulatory Updates
Sep 27, 2026•1 min read
FDA Approves ANDA 077973 for Bicalutamide 50 mg Tablet – Synthon Pharm
FDA approves ANDA 077973 for Synthon Pharm’s 50 mg oral bicalutamide tablet; labeling approved in 2009 and manufacturing in 2011.